Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma

Peptides

Volumn 29, Issue 9, 2008, Pages 1609-1615

  Gui, Xianyong ^a   Guzman, Grace ^a   Dobner, Paul R ^b   Kadkol, ShriHari S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Colorectal cancer; Gene expression; Peptide

Indexed keywords

NEUROTENSIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL GROWTH; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, NEUROTENSIN; RNA, MESSENGER;

EID: 49049110032     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.04.014     Document Type: Article

References (35)

1. Banker N.A., Hellmich M.R., Kim H.J., Townsend Jr. C.M., and Evers B.M. Src-mediated activation of the human neurotensin/neuromedin N promoter. Surgery 122 (1997) 180-185
2. i in enteric endocrine cells. Am J Physiol 261 (1991) G497-G503
3. Bossard C., Souazé F., Jarry A., Bezieau S., Mosnier J.-F., Forgez P., et al. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear β-catenin in inflammatory bowel disease-related oncogenesis. Peptides 28 (2007) 2030-2035
4. Brabletz T., Jung A., Hermann K., Günther K., Hohenberger W., and Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194 (1998) 701-704
5. Castagliuolo I., Wang C.-C., Valenick L., Pasha A., Nikulasson S., Carraway R.E., et al. Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J Clin Invest 103 (1999) 843-849
6. Chao C., Tallman M.L., Ives K.L., Townsend Jr. C.M., and Hellmich M.R. Gastrointestinal hormone receptors in primary human colorectal cancers. J Surg Res 129 (2005) 313-321
7. Evers B.M., Izukura M., Townsend Jr. C.M., Uchida T., and Thompson J.C. Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet. Ann Surg 211 (1990) 630-636
8. Evers B.M., Izukura M., Chung D.H., Parekh D., Youshinaga K., Greeley Jr. G.H., et al. Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology 103 (1992) 86-91
9. Evers B.M., Izukura M., Townsend Jr. C.M., Uchida T., and Thompson J.C. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci 37 (1992) 426-431
10. Evers B.M., Rajaraman S., Chung D.H., Townsend Jr. C.M., Wang X., Graves K., et al. Differential expression of the neurotensin gene in the developing rat and human gastrointestinal tract. Am J Physiol 265 (1993) G482-G490
11. Evers B.M., Zhou Z., Celano P., and Li J. The neurotensin gene is a downstream target for Ras activation. J Clin Invest 95 (1995) 2822-2830
12. Evers B.M., Zhou A., Dohlen V.B.A., Rajaraman S., Thompson J.C., and Townsend Jr. C.M. Fetal and neoplastic expression of the neurotensin gene in the human colon. Ann Surg 223 (1996) 464-470
13. Ferris C.F., Armstrong M.J., George J.K., Stevens C.A., Carraway R.E., and Leeman S.E. Alcohol and fatty acid stimulation of neurotensin release from rat small intestine. Endocrinology 116 (1985) 1133-1138
14. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168 (2005) 633-642
15. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
16. Hlubek F., Spaderna S., Jung A., Kirchner T., and Brabletz T. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma 2 chain and MT1-MMP in colorectal carcinoma. Int J Cancer 108 (2004) 321-326
17. Jung A., Schrauder M., Oswald U., Knoll C., Sellberg P., Palmqvist R., et al. The invasion front of human colorectal adenocarcinomas show co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 159 (2001) 1613-1617
18. Kadkol S.S., Brody J.R., Epstein J.L., Kuhajda F.P., and Pasternack G.R. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer. Prostate 34 (1998) 231-237
19. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
20. Knute D.P., Wali R.K., Koetsier J.L., Hart J., Kostjukova M.N., Kilimnik A.Y., et al. Down-regulation of the tumor supressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation. FEBS Lett 579 (2005) 3497-3502
21. Maoret J.-J., Pospai D., Rouyer-Fessard C., Couvineau A., Laboisse C., Voisin T., et al. Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Bichem Biophys Res Commun 203 (1994) 465-471
22. Maoret J.-J., Anini Y., Rouyer-Fessard C., Gully D., and Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer 80 (1999) 448-454
23. Muraki K., Nishi Y., Okahata H., Arai M., Yamada H., Fujita S., et al. Ontogenic development of neurotensin-like immunoreactivity in the gastrointestinal tract and the influence of dietary changes in rats. J Pediatr Gastroenterol Nutr 6 (1987) 290-295
24. Potten C.S., Booth C., and Pritchard D.M. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 78 (1997) 219-243
25. Rovère C., Barbero P., Maoret J.-J., Laburthe M., and Kitabgi P. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines. Biochem Biophys Res Commun 246 (1998) 155-159
26. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96 (1999) 5522-5527
27. Somaï S., Gompel A., Rostène W., and Forgez P. Neurotensin counteracts apoptosis in breast cancer cells. Biochem Biophys Res Commun 295 (2002) 482-488
28. Souazè F., Viardot-Foucault V., Roullet N., Toy-Miou-Leong M., Gompel A., Bruyneel E., et al. Neurotensin receptor 1 gene activation by the Tcf/β-catenin pathway is an early event in human colonic adenomas. Carcinogenesis 27 (2006) 708-716
29. Tatsuta M., Iishi H., Baba M., and Taniguchi H. Enhancement by neurotensin of experimental carcinogenesis induced in rat colon by azoxymethane. Br J Cancer 62 (1990) 368-371
30. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
31. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
32. Völp K., Brezniceanu M.L., Bosser S., Brabletz T., Kirchner T., Göttel D., et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55 (2006) 234-242
33. Wood J.G., Hoang H.D., Bussjaeger L.J., and Solomon T.E. Neurotensin stimulates growth of small intestine in rats. Am J Physiol 255 (1988) G813-G817
34. Yoshinaga K., Evers B.M., Izukura M., Parekh D., Uchida T., Townsend Jr. C.M., et al. Neurotensin stimulates growth of colon cancer. Surg Oncol 1 (1992) 127-134
35. Zhang T., Otevrel T., Gao Z., Gao Z., Ehrlich S.M., Fields J.Z., and Boman B.M. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61 (2001) 8664-8667